• contact@starkagetx.com
    +33 3 74 02 03 03
StarkAge Therapeutics

  • Our Company
    • Senior Management
    • Scientific Advisory Board
  • Our Approach
  • News
  • Contact
All news
We are sharing here our key business / corporate news and Press Releases, as well major scientific news and data.

Filter by

novembre 27, 2024
Estimated reading time : 1 min.
Articles
NewsLetter #6
Read the article
mai 27, 2024
Estimated reading time : 1 min.
Articles
StarkAge Therapeutics at AACR 2024 (San Diego)
Read the article
octobre 9, 2022
Estimated reading time : 1 min.
Articles
StarkAge Therapeutics present their most recent findings at ICSA 2022
Read the article
août 23, 2022
Estimated reading time : 2 mins.
Articles
Identification of senescent cell surface markers as immunotherapeutic targets
Read the article
Read or download all Corporate Press Releases
Appointment of Dr. Benjamin LeCalvé as Chief Executive Officer (CEO) of StarkAge Therapeutics
Nov 26, 2024
Read the document
StarkAge Therapeutics raises €1.2m to accelerate the development of STX-1
Mai 29, 2024
Read the document
Starkage Therapeutics appoints Benjamin Le Calvé as CSO
Mai 10, 2022
Read the document
StarkAge Therapeutics establishes its Scientific Advisor Board of international independent experts and has their foundational meeting
Fév 13, 2022
Read the document
StarkAge Therapeutics awarded €2m from BPI France to develop innovative immunotherapy approach targeting senescent cells in age-related diseases
Jan 18, 2022
Read the document

Want to receive news from StarkAge Therapeutics ?

Subscribe now to our newsletter to discover:

  • All the news from StarkAge Therapeutics
  • Latest published articles
  • Our news

Click here to be updated on news from StarkAge Therapeutics

Address

Campus de l’Institut Pasteur Lille

1 Rue du Professeur Calmette

59800 Lille

Email Us

contact@starkagetx.com
StarkAge Therapeutics © 2022 - All Rights Reserved
About | We are Hiring | Legal | Privacy Policy | Cookies